The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, Catherina Luyten, Katrien Drijkoningen, Frederic Amant, Karin Leunen, Ignace Vergote

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)64-68
JournalGynecologic Oncology
Volume118
Issue number1
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Ovarian cancer
  • Enzastaurin
  • Biomarker
  • CA 125
  • OVCAR-3 cells

Cite this

Cadron, I., Van Gorp, T., Mihalyi, A., Luyten, C., Drijkoningen, K., Amant, F., Leunen, K., & Vergote, I. (2010). The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells. Gynecologic Oncology, 118(1), 64-68. https://doi.org/10.1016/j.ygyno.2010.03.008